Awkward photo with the band as a mandatory part of @MOGA_ORG ASM #MOGA24 @oncology_bg

Job Opportunity: Calvary Mater Newcastle seeks Medical Oncology Advanced Trainee. Fixed term full-time. Closes 21 July. https://t.co/VhlHaFfBxb

Join our #MedicalOncology team in Newcastle as a #ClinicalTrial Fellow. One of NSW busiest clinical research teams, gain wide experience and see many opportunities. Immediate start, FT or PT, and multi-year possible. https://t.co/buxjB63ayd Credit: Ian Nord

Medical Oncologist roles at #CalvaryMaterNewcastle. Join our busy academic service. Two Permanent Part-time Positions (0.5 FTE/20 hours per week) https://t.co/UE81b8isHc Please share.

A big welcome to the 20 new ESMO Designated Centres of Integrated #Oncology & #PalliativeCare 🔗 https://t.co/1HQ34EPofh @MOU_Brno @adrziekenhuis @HBCHRCVIZAG @MLauraVillal @SaludMadrid @BurjeelMediCity @alshamsi2000 @CalvaryCareAUS @drjameslynam @ICM_Montpellier @ASLCittaTorino

8/ Pembrolizumab significantly improved DFS as compared to placebo (HR=0.68 ; 95%CI: 0.53-0.87 ; p=0.002, 2-sided), with benefits identified across most key subgroups (all HR<1). DFS rates at 2 years were 77.3 and 68.1% in the pembrolizumab and placebo groups, respectively.

Great kick off of the inaugural @MOGA_ORG #OPAL21 Leadership Course. Much gratitude to @sandraturner49 @lucindamorris23 Matthew Seel @DrBenKong & @jess_louise_s for making it happen 👏👏👏

Merck’s KEYTRUDA® (pembrolizumab) Demonstrated Superior Disease-Free Survival (DFS) Compared With Placebo as Adjuvant Therapy in Patients With Renal Cell Carcinoma (RCC) Following Surgery | Business Wire

Great work by @dr_benoy_n_shah !! I shudder to think of a similar study in Oncology!! Analysis of conflicts of interest among authors and researchers of European clinical guidelines in cardiovascular medicine

A friend has just shown me this book "Calculus made easy", published in 1914, and I think it's got one of the best prologues I've ever seen. This is *exactly* what textbooks should be doing. And they should all be honest about how terrifying the topic names are too.

Now, this is a story all about how My training got flipped-turned upside down And I liked to take a minute Just sit right there I'll tell you how I became redeployed in crit care.

A long year comes to an end. Looking through this list there are so many people can’t be replaced. Oddly enough the one that affected me the most was June Benicoff. I hope she’s happy being reunited with Leon!

Hi, ER Doc here. RT if you’ve ever done CPR on someone and they survived. Trying to prove something.

The Cancer Clinical Research Network at @HNEHealth! Accepted by Dr James Lynam and Rosemary Carroll on behalf of the many people involved across the entire Network. Congratulations, team! #cancerNSWawards

Congratulations to the Cancer Clinical Research Network and @HNEHealth – 2020 Outstanding Cancer Clinical Trials Unit. Find out more about their work to lead clinical trial recruitment and enrolment: https://t.co/UvFJJ4jq8B #cancerNSWawards

Find out how the Cancer Clinical Research Network is striving to break down geographical boundaries – giving more people in the Hunter New England region access to potentially life-changing clinical trials. https://t.co/UvFJJ4B109 #cancerNSWawards

This is probably the most balanced and fair assessment of the Charlie Teo enigma. “Like shooting Bambi': why Teo critics were gun-shy as media built the miracle-surgeon myth” https://t.co/j1oojipjPh

https://t.co/1B6Z0mw1Ud

Characteristics of 6,801 #COVID19 patients dying in Italy🇮🇹: median age 78, men 70.4%. Pre-existing conditions available in 710 patients dying in-hospital: 17% active #cancer in the past 5 years. Time from hospitalization to death only 2 days longer if ICU (6d vs. 4d) @istsupsan